Novartis

SouthViews No. 182, 11 July 2019

The most expensive drug in the history of the pharmaceutical industry

By Germán Velásquez

On May 27, 2019 the US FDA gave marketing authorization for Zolgensma gene therapy, from the Swiss firm Novartis. The price of the drug, administered in a single dose, is 2.125 million dollars, making it the most expensive drug in the history of the pharmaceutical industry. (more…)

0

Your Cart